Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 who have given their consent and have been diagnosed with ulcerative colitis (a type of inflammatory bowel condition affecting the large intestine) for at least 3 years.
- People whose ulcerative colitis is in "deep remission," meaning a colonoscopy performed within the last 12 months showed no signs of active inflammation in the tissue samples taken — or, if the most recent colonoscopy was within the last 3 years and showed the same result, a consistently normal stool test result (called a calprotectin test) may be accepted instead (confirm with trial site).
- People who have been in full remission — with no symptoms, normal stool test results (calprotectin below 100), normal imaging, and no signs of inflammation on colonoscopy — since their last colonoscopy.
Who may not be able to join:
- People who have any signs of active inflammation, whether through symptoms, ultrasound, blood or stool tests, or colonoscopy findings in any part of the large intestine.
- People who have changed their ulcerative colitis treatment at any point after a colonoscopy confirmed their inflammation had settled.
- People who have used corticosteroid medications (a type of anti-inflammatory drug) after a colonoscopy confirmed their inflammation had settled.
- People who have a history of a liver condition called primary sclerosing cholangitis, or who have been found to have high-grade dysplasia (abnormal cells that could indicate a risk of cancer) that could not be seen clearly or was not removed.
- People who are pregnant or actively trying to become pregnant.
- People who would not be able to follow the required sample collection and monitoring schedule throughout the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David T Rubin, MD, University of Chicago
Phone: 215-596-9715
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of individuals with sustained biochemical remission; Number of individuals with sustained sonographic remission; Number of individuals with sustained clinical remission; Number of individuals with sustained endoscopic remission
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.